D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
1401
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.66M | ﹤0.01% |
896,796
+441,973
| +97% | +$1.31M |
|
|
PLAN
1402
DELISTED
Anaplan, Inc.
PLAN
| $2.64M | ﹤0.01% |
+67,156
| New | +$2.64M |
|
|
CHUY
1403
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.63M | ﹤0.01% |
115,555
-48,409
| -30% | -$1.1M |
|
|
ZGNX
1404
DELISTED
Zogenix, Inc.
ZGNX
| $2.63M | ﹤0.01% |
47,813
-8,336
| -15% | -$459K |
|
1405
WPP
WPP
$5.86B
| $2.62M | ﹤0.01% |
49,613
-112,812
| -69% | -$5.96M |
|
1406
Ethan Allen Interiors
ETD
$742M
| $2.61M | ﹤0.01% |
136,373
-27,895
| -17% | -$534K |
|
1407
Karyopharm Therapeutics
KPTI
$55.9M
| $2.61M | ﹤0.01% |
29,758
+18,447
| +163% | +$1.62M |
|
1408
InflaRx
IFRX
$85.4M
| $2.6M | ﹤0.01% |
68,901
+53,353
| +343% | +$2.02M |
|
1409
Intuit
INTU
$180B
| $2.6M | ﹤0.01% |
9,927
-24,999
| -72% | -$6.53M |
|
1410
Arthur J. Gallagher & Co
AJG
$76.2B
| $2.59M | ﹤0.01% |
33,185
+21,096
| +175% | +$1.65M |
|
1411
Sabra Healthcare REIT
SBRA
$4.57B
| $2.59M | ﹤0.01% |
132,849
-780,962
| -85% | -$15.2M |
|
|
AEL
1412
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.57M | ﹤0.01% |
95,085
-1,852
| -2% | -$50.1K |
|
|
MGI
1413
DELISTED
MoneyGram International, Inc. New
MGI
| $2.57M | ﹤0.01% |
1,258,882
-14,084
| -1% | -$28.7K |
|
|
GNMK
1414
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.57M | ﹤0.01% |
362,148
+9,184
| +3% | +$65.1K |
|
1415
SSR Mining
SSRM
$4.54B
| $2.57M | ﹤0.01% |
202,680
-8,485
| -4% | -$107K |
|
|
FLNT
1416
Fluent
FLNT
$49M
| $2.56M | ﹤0.01% |
75,863
+8,065
| +12% | +$272K |
|
1417
Empire State Realty Trust
ESRT
$1.34B
| $2.55M | ﹤0.01% |
161,540
-95,074
| -37% | -$1.5M |
|
|
RUTH
1418
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $2.54M | ﹤0.01% |
99,171
+12,326
| +14% | +$315K |
|
1419
Potbelly
PBPB
$514M
| $2.51M | ﹤0.01% |
295,409
+96,335
| +48% | +$820K |
|
1420
Ryder
R
$7.65B
| $2.51M | ﹤0.01% |
40,544
-70,649
| -64% | -$4.38M |
|
1421
Sportsman's Warehouse
SPWH
$117M
| $2.51M | ﹤0.01% |
523,484
+153,050
| +41% | +$735K |
|
|
FPI
1422
Farmland Partners
FPI
$481M
| $2.51M | ﹤0.01% |
392,526
+62,110
| +19% | +$397K |
|
1423
MediciNova
MNOV
$60.3M
| $2.5M | ﹤0.01% |
302,080
+35,737
| +13% | +$295K |
|
|
ICPT
1424
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.5M | ﹤0.01% |
22,303
-191,037
| -90% | -$21.4M |
|
1425
Andersons Inc
ANDE
$1.38B
| $2.48M | ﹤0.01% |
77,025
+25,869
| +51% | +$834K |
|